戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tients with systemic lupus erythematosus and autoimmune lymphoproliferative syndrome.
2 e classified the disease as a variant of the autoimmune lymphoproliferative syndrome.
3  disease to differentiate this disorder from autoimmune lymphoproliferative syndrome.
4 nesis of autoimmunity and lymphomagenesis of autoimmune lymphoproliferative syndrome.
5 th Fas-induced lymphocyte apoptosis in human autoimmune lymphoproliferative syndrome.
6 ade FADD a candidate susceptibility gene for autoimmune lymphoproliferative syndrome.
7                   All children (N = 12) with autoimmune lymphoproliferative syndrome (ALPS) achieved
8                                          The autoimmune lymphoproliferative syndrome (ALPS) affords n
9 Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and domin
10                                Patients with autoimmune lymphoproliferative syndrome (ALPS) and syste
11 ts in lymphocyte apoptosis that underlie the autoimmune lymphoproliferative syndrome (ALPS) are usual
12                                              Autoimmune lymphoproliferative syndrome (ALPS) caused by
13 tions of the Fas gene can result in a severe autoimmune lymphoproliferative syndrome (ALPS) in humans
14                                              Autoimmune lymphoproliferative syndrome (ALPS) is a diso
15                                              Autoimmune lymphoproliferative syndrome (ALPS) is a diso
16                                              Autoimmune lymphoproliferative syndrome (ALPS) is a diso
17                                              Autoimmune lymphoproliferative syndrome (ALPS) is a diso
18                                              Autoimmune lymphoproliferative syndrome (ALPS) is a huma
19                                              Autoimmune lymphoproliferative syndrome (ALPS) is a huma
20                                              Autoimmune lymphoproliferative syndrome (ALPS) is a huma
21                                              Autoimmune Lymphoproliferative Syndrome (ALPS) is a rece
22                                              Autoimmune lymphoproliferative syndrome (ALPS) is an inh
23                                              Autoimmune lymphoproliferative syndrome (ALPS) is caused
24                                              Autoimmune lymphoproliferative syndrome (ALPS) is charac
25                                          The autoimmune lymphoproliferative syndrome (ALPS) is charac
26                                              Autoimmune lymphoproliferative syndrome (ALPS) is charac
27                           The human disease, Autoimmune Lymphoproliferative Syndrome (ALPS) is due to
28                                              Autoimmune lymphoproliferative syndrome (ALPS) is marked
29                                              Autoimmune lymphoproliferative syndrome (ALPS) is the mo
30 , immunological, and clinical aspects of the autoimmune lymphoproliferative syndrome (ALPS) met in Be
31 ice et al document a 20-year experience with autoimmune lymphoproliferative syndrome (ALPS) patients
32  T cells with a phenotype similar to that in autoimmune lymphoproliferative syndrome (ALPS) patients.
33                                              Autoimmune lymphoproliferative syndrome (ALPS) presents
34                                              Autoimmune lymphoproliferative syndrome (ALPS) represent
35 ressing Fas mutations from patients with the autoimmune lymphoproliferative syndrome (ALPS) reveals t
36                                              Autoimmune lymphoproliferative syndrome (ALPS) type Ia i
37             We report here two kindreds with autoimmune lymphoproliferative syndrome (ALPS) type II,
38 al. explore somatic changes in patients with autoimmune lymphoproliferative syndrome (ALPS), a congen
39  ligand or caspase-10 underlie most cases of autoimmune lymphoproliferative syndrome (ALPS), a human
40                                A hallmark of autoimmune lymphoproliferative syndrome (ALPS), caused b
41 ototype for human apoptosis disorders is the autoimmune lymphoproliferative syndrome (ALPS), which is
42 uble-negative T cells (DNT) is a hallmark of autoimmune lymphoproliferative syndrome (ALPS).
43 nd cause recessively or dominantly inherited autoimmune lymphoproliferative syndrome (ALPS).
44 nd show remarkable efficacy in children with autoimmune lymphoproliferative syndrome (ALPS).
45      Lymphomas were studied in kindreds with autoimmune lymphoproliferative syndrome (ALPS; Canale-Sm
46                                           In autoimmune/lymphoproliferative syndrome (ALPS), defectiv
47 d exome sequencing in a patient with NDM and autoimmune lymphoproliferative syndrome and his unrelate
48  have revealed an ever-expanding spectrum of autoimmune lymphoproliferative syndrome and its major co
49 Gadd45gamma spontaneously developed signs of autoimmune lymphoproliferative syndrome and systemic lup
50 sociated with inherited human mutations: the autoimmune lymphoproliferative syndrome and the caspase-
51                                              Autoimmune lymphoproliferative syndrome arises early in
52 n humans, fas mutations result in a familial autoimmune lymphoproliferative syndrome, but defects in
53            In lpr/lpr mice and children with autoimmune lymphoproliferative syndrome, defective apopt
54                                           In autoimmune lymphoproliferative syndrome, defective lymph
55 tosus, common variable immunodeficiency, and autoimmune lymphoproliferative syndromes, hemophagocytic
56 for caspase-10, previously implicated in the autoimmune lymphoproliferative syndrome, in death recept
57                                Most cases of autoimmune lymphoproliferative syndrome involve heterozy
58 ed-coil domain of STAT5B that presented with autoimmune lymphoproliferative syndrome-like features.
59  suggests potential treatments for lupus and autoimmune lymphoproliferative syndrome, without comprom

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。